Meritage Portfolio Management cut its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 0.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 65,558 shares of the biopharmaceutical company’s stock after selling 342 shares during the quarter. Meritage Portfolio Management’s holdings […]
Meritage Portfolio Management lessened its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 0.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 65,558 shares of the biopharmaceutical company’s stock after selling 342 shares during the […]
Gilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) was the recipient of unusually large options trading activity on Thursday. Investors bought 42,588 put options on the stock. This represents an increase of 240% compared to the average volume of 12,513 put options. Gilead Sciences Trading Down 2.3 % Shares of NASDAQ:GILD traded down $1.53 during […]
Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) – Equities researchers at Zacks Research decreased their Q1 2024 EPS estimates for Gilead Sciences in a report released on Tuesday, April 23rd. Zacks Research analyst E. Bagri now anticipates that the biopharmaceutical company will post earnings of ($1.42) per share for the quarter, down from their prior […]
Gilead Sciences (GILD) Set to Announce Quarterly Earnings on Thursday theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.